Difference between revisions of "Team:Shanghai Metro/Collaborations"

(Prototype team page)
 
 
(9 intermediate revisions by 2 users not shown)
Line 1: Line 1:
−
{{IGEM_TopBar}}
+
<html lang="en">
−
{{Shanghai_Metro}}
+
−
<html>
+
  
 +
<head>
 +
    <meta charset="UTF-8">
 +
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
 +
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
 +
    <title>Shanghai_Metro</title>
 +
    <link rel="stylesheet"
 +
        href="https://2021.igem.org/wiki/index.php?title=Template:Shanghai_Metro/Main_CSS&action=raw&ctype=text/css" />
  
−
<div class="column full_size judges-will-not-evaluate">
+
</head>
−
<h3>★  ALERT! </h3>
+
−
<p>This page is used by the judges to evaluate your team for the <a href="https://2021.igem.org/Judging/Medals">medal criterion</a> or <a href="https://2021.igem.org/Judging/Awards"> award listed below</a>. </p>
+
−
<p> Delete this box in order to be evaluated for this medal criterion and/or award. See more information at <a href="https://2021.igem.org/Judging/Pages_for_Awards"> Instructions for Pages for awards</a>.</p>
+
−
</div>
+
−
 
+
−
 
+
−
<div class="clear"></div>
+
−
 
+
−
 
+
−
<div class="column full_size">
+
−
<h1>Collaborations</h1>
+
−
 
+
−
<p>
+
−
Sharing and collaboration are core values of iGEM. We encourage you to reach out and work with other teams on difficult problems that you can more easily solve together.
+
−
</p>
+
−
 
+
−
<h3>Silver Medal Criterion #2</h3>
+
−
<p>
+
−
Document your collaboration(s) clearly on this page to compete for the silver medal criterion #2 on collaboration.
+
−
 
+
−
<br><br>
+
−
Please see the <a href="https://2021.igem.org/Judging/Medals">2021 Medals Page</a> for more information.
+
−
</p>
+
−
</div>
+
−
 
+
−
<div class="column two_thirds_size">
+
−
 
+
−
<h4> Which teams can we work with? </h4>
+
−
<p>
+
−
You can work with any other iGEM 2021 team in the competition. You can also work with non-iGEM research groups, but they do not count towards the iGEM team collaboration silver medal criterion.
+
−
</p>
+
−
 
+
−
 
+
−
</div>
+
−
 
+
−
 
+
−
 
+
−
<div class="column third_size">
+
−
<p>
+
−
Here are some suggestions for projects you could work on with other teams:
+
−
</p>
+
−
 
+
−
<ul>
+
−
<li> Improve the function of another team's BioBrick Part or Device</li>
+
−
<li> Characterize another team's part </li>
+
−
<li> Debug a construct </li>
+
−
<li> Model or simulate another team's system </li>
+
−
<li> Test another team's software</li>
+
−
<li> Help build and test another team's hardware project</li>
+
−
<li> Mentor a high-school team</li>
+
−
</ul>
+
−
</div>
+
  
 +
<body>
 +
    <nav class="head-nav clearfix">
 +
        <div class="top-block"></div>
 +
        <div class="top-nav-bar">
 +
            <ul class="clearfix">
 +
                <span class="small-logo"></span>
 +
                <li>
 +
                    <a href="https://2021.igem.org/Team:Shanghai_Metro">Home</a>
 +
                </li>
 +
                <li>
 +
                    <a href="">Project</a>
 +
                    <div class="sub-nav">
 +
                        <ul>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Description"
 +
                                    class="sub-nav-74">Description</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Experiments"
 +
                                    class="sub-nav-74">Experiments</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Results"
 +
                                    class="sub-nav-74">Results</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Proof_Of_Concept"
 +
                                    class="sub-nav-52">Proof Of Concept</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Notebook"
 +
                                    class="sub-nav-52">Notebook</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Safety">Safety</a></li>
 +
                        </ul>
 +
                    </div>
 +
                </li>
 +
                <li>
 +
                    <a href="">Parts</a>
 +
                    <div class="sub-nav">
 +
                        <ul>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Parts" class="sub-nav-74">Parts
 +
                                    Collection</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Engineering"
 +
                                    class="sub-nav-74">Engineering</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Contribution"
 +
                                    class="sub-nav-74">Contribution</a></li>
 +
                        </ul>
 +
                    </div>
 +
                </li>
 +
                <li>
 +
                    <a href="">Human Practices</a>
 +
                    <div class="sub-nav">
 +
                        <ul>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Human_Practices"
 +
                                    class="sub-nav-74">Integrated Human Practice</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Communication"
 +
                                    class="sub-nav-74">Communication</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Fundraising"
 +
                                    class="sub-nav-74">Fundraising</a></li>
 +
                        </ul>
 +
                    </div>
 +
                </li>
 +
                <li>
 +
                    <a href="https://2021.igem.org/Team:Shanghai_Metro/Implementation">Implementation</a>
 +
                </li>
 +
                <li>
 +
                    <a href="https://2021.igem.org/Team:Shanghai_Metro/Entrepreneurship">Entrepreneurship</a>
 +
                </li>
 +
                <li>
 +
                    <a href="https://2021.igem.org/Team:Shanghai_Metro/Model">Model</a>
 +
                </li>
 +
                <li class="active">
 +
                    <a href="">Team</a>
 +
                    <div class="sub-nav">
 +
                        <ul>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Members" class="sub-nav-74">Team
 +
                                    Members</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Attributions"
 +
                                    class="sub-nav-74">Attributions</a></li>
 +
                            <li class="current-sub-nav"><a href="#" class="sub-nav-74">Collaborations</a></li>
 +
                            <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Partnership"
 +
                                    class="sub-nav-74">Partnership</a></li>
 +
                        </ul>
 +
                    </div>
 +
                </li>
 +
            </ul>
 +
        </div>
 +
    </nav>
 +
    <div class="sub-content">
 +
        <div class="sub-title">Team Collaboration with Dr.PHAGE</div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/6/69/T--Shanghai_Metro--Collaboration01.jpg" alt="" />
 +
            <span>Shanghai_United_HS & Shanghai_Metro</span>
 +
        </div>
 +
        <div class="article-content">Since both our team and Dr.Phage team have some members who have done genetic
 +
            engineering type experiments in the lab before, we decided to enhance the projects of our two groups by
 +
            sharing our experimental experiences. We helped them by discussing and verifying their experimental steps
 +
            and inserting our plasmids carrying tke and ike into their E.Coli strains, we may use our research to
 +
            encrypt their products and prevent unauthorized uses.</div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/3/3e/T--Shanghai_Metro--Collaboration02.jpg" alt="" />
 +
        </div>
 +
        <div class="article-content">Team Dr.PHAGE designed a genetically engineered probiotic guided by arabinoxylan to
 +
            secrete ClyR to prevent and treat dental caries. And our patented strain protection technology can play the
 +
            role of protecting strains. Taking this as an opportunity, we converted our opinions through online
 +
            communication, raised problems we encountered, and expressed our willingness to cooperate. In the end, we
 +
            decided to carry out various forms of cooperation, including technical and publicity.</div>
 +
        <div class="img-wrap no-margin">
 +
            <img src="https://static.igem.org/mediawiki/2021/b/b9/T--Shanghai_Metro--2-3X4-1.jpg" alt="">
 +
            <span>Shanghai_Metro & Xiamen_City </span>
 +
        </div>
 +
        <div class="article-content">
 +
            After discussing with PecTeast (Xiamen_City), they discovered our team can primarily increase the value of
 +
            their project. Once They multifunctional yeast spreads out, Their customers may likely duplicate it by
 +
            themselves without their permission. Because without specific requirements of living environments, Their
 +
            yeast can increase in the most straightforward conditions.
 +
        </div>
 +
        <div class="article-content">Our project serves to protect the patent by chemically transferring a designed
 +
            plasmid into E. coli DH5α. </div>
 +
        <div class="article-content">Therefore, we only need to extract the gene of the designed plasmid (either
 +
            ike2-tke2 or ike4-tke4, only one of them), amplify this gene by pcr, and recreate the homologous
 +
            recombination template by CRISPR-Cas technology to integrate the gene of this segment to the yeast genome.
 +
        </div>
 +
        <div class="article-content">We do not need to redesign the tke effector and ike immune factor, both universal.
 +
            After gene editing, patent protection can be achieved by simply putting the yeast into the specified
 +
            substance so as to protect their engineered yeast.</div>
 +
        <div class="article-content">This issue greatly solves the current headache of patenting.</div>
 +
    </div>
 +
    <footer class="footer">
 +
        <section class="footer-wrap">
 +
            <p class="contact-tips">Contact Info.</p>
 +
            <hr class="line" />
 +
            <p class="margin-bottom-8">Email: <i style="color:#0030e4;">binghan423@163.com; runshigu@126.com</i></p>
 +
            <p>Wechat Official Account: IGEM VIPatent</p>
 +
        </section>
 +
    </footer>
 +
</body>
 +
<script>
 +
    let liTags = document.querySelectorAll(".top-nav-bar > ul > li");
 +
    let len = liTags.length;
 +
    for (let i = 0; i < len; i++) {
 +
        liTags[i].onclick = function (e) {
 +
            //先移除所有的点击样式
 +
            for (let j = 0; j < len; j++) {
 +
                liTags[j].classList.remove("active");
 +
            }
 +
            //再添加点击样式
 +
            let li = e.currentTarget;
 +
            li.classList.add("active");
 +
        }
 +
    }
 +
</script>
  
 
</html>
 
</html>

Latest revision as of 13:44, 20 October 2021

Shanghai_Metro

Team Collaboration with Dr.PHAGE
Shanghai_United_HS & Shanghai_Metro
Since both our team and Dr.Phage team have some members who have done genetic engineering type experiments in the lab before, we decided to enhance the projects of our two groups by sharing our experimental experiences. We helped them by discussing and verifying their experimental steps and inserting our plasmids carrying tke and ike into their E.Coli strains, we may use our research to encrypt their products and prevent unauthorized uses.
Team Dr.PHAGE designed a genetically engineered probiotic guided by arabinoxylan to secrete ClyR to prevent and treat dental caries. And our patented strain protection technology can play the role of protecting strains. Taking this as an opportunity, we converted our opinions through online communication, raised problems we encountered, and expressed our willingness to cooperate. In the end, we decided to carry out various forms of cooperation, including technical and publicity.
Shanghai_Metro & Xiamen_City
After discussing with PecTeast (Xiamen_City), they discovered our team can primarily increase the value of their project. Once They multifunctional yeast spreads out, Their customers may likely duplicate it by themselves without their permission. Because without specific requirements of living environments, Their yeast can increase in the most straightforward conditions.
Our project serves to protect the patent by chemically transferring a designed plasmid into E. coli DH5α.
Therefore, we only need to extract the gene of the designed plasmid (either ike2-tke2 or ike4-tke4, only one of them), amplify this gene by pcr, and recreate the homologous recombination template by CRISPR-Cas technology to integrate the gene of this segment to the yeast genome.
We do not need to redesign the tke effector and ike immune factor, both universal. After gene editing, patent protection can be achieved by simply putting the yeast into the specified substance so as to protect their engineered yeast.
This issue greatly solves the current headache of patenting.

Contact Info.

Email: binghan423@163.com; runshigu@126.com

Wechat Official Account: IGEM VIPatent